We have located links that may give you full text access.
Remote Contrast Sensitivity Testing Appears to Correlate With Degree of Glaucomatous Macular Damage.
Journal of Glaucoma 2023 March 4
PRECIS: Remote contrast sensitivity testing via a free downloadable home test correlates with glaucomatous macular damage measured by 10-2 visual field testing.
PURPOSE: To assess the feasibility and validity of home contrast sensitivity monitoring as a measure of glaucomatous damage using a free downloadable smart phone application.
METHODS: 26 participants were asked to remotely use the Berkeley Contrast Squares application, a free downloadable tool that records users' contrast sensitivity for varying degrees of visual acuity. An instructional video detailing how to download and use the application was sent to the participants. Subjects were asked to send logarithmic contrast sensitivity results with a minimum 8 week test-retest window, and test-retest reliability was measured. Results were validated against office-based contrast sensitivity testing that was collected within the previous 6 months. Validity analysis was also carried out to determine if contrast sensitivity as measured by Berkeley Contrast Squares is a good predictor of 10-2 and 24-2 visual field mean deviation.
RESULTS: There was a high Berkeley Contrast Squares test-retest reliability with an intraclass correlation coefficient score of 0.91 and significant correlation between repeat test results and baseline test scores (Pearson 0.86, P<0.0001). There was significant agreement between unilateral contrast sensitivity scores as measured by Berkeley Contrast Squares and office-based contrast sensitivity testing (b=0.94, P<0.0001, 95% CI [0.61 to 1.27]). Unilateral contrast sensitivity as measured by Berkeley Contrast Squares was significantly associated with 10-2 visual field mean deviation (r2=0.27, P= 0.006, 95% CI [3.7 to 20.6]), but not with 24-2 visual field mean deviation (P=0.151).
CONCLUSION: This study suggests that a free, rapid home contrast sensitivity test correlates with glaucomatous macular damage as measured by 10-2 visual field.
PURPOSE: To assess the feasibility and validity of home contrast sensitivity monitoring as a measure of glaucomatous damage using a free downloadable smart phone application.
METHODS: 26 participants were asked to remotely use the Berkeley Contrast Squares application, a free downloadable tool that records users' contrast sensitivity for varying degrees of visual acuity. An instructional video detailing how to download and use the application was sent to the participants. Subjects were asked to send logarithmic contrast sensitivity results with a minimum 8 week test-retest window, and test-retest reliability was measured. Results were validated against office-based contrast sensitivity testing that was collected within the previous 6 months. Validity analysis was also carried out to determine if contrast sensitivity as measured by Berkeley Contrast Squares is a good predictor of 10-2 and 24-2 visual field mean deviation.
RESULTS: There was a high Berkeley Contrast Squares test-retest reliability with an intraclass correlation coefficient score of 0.91 and significant correlation between repeat test results and baseline test scores (Pearson 0.86, P<0.0001). There was significant agreement between unilateral contrast sensitivity scores as measured by Berkeley Contrast Squares and office-based contrast sensitivity testing (b=0.94, P<0.0001, 95% CI [0.61 to 1.27]). Unilateral contrast sensitivity as measured by Berkeley Contrast Squares was significantly associated with 10-2 visual field mean deviation (r2=0.27, P= 0.006, 95% CI [3.7 to 20.6]), but not with 24-2 visual field mean deviation (P=0.151).
CONCLUSION: This study suggests that a free, rapid home contrast sensitivity test correlates with glaucomatous macular damage as measured by 10-2 visual field.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app